Transgenomic, Inc. (TBIO) |
|---|
| $0.15 52 Week Low | $0.37 2017-04-28 14:02:58 MDT | $1.59 52 Week High |
| Technology Sector | Scientific Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $11,420,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | -0.51 | Unusual negative beta. Good for diversity? Stock may go up when market goes down, and down when market goes up. |
ForwardPE: Unknown | 5 Yr Est Growth: 20.00% | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -33.93% | % Above 200 DayMA: -15.91% |
TBIO Performance 52 Weeks: -32.81% | S&P 500 Performance 52 Weeks: 13.50% |
Downtrend is still intact: TBIO is below both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | TBIO underperforming S&P 500 by -46.31% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -2.84 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 18.61% | 17.28% | Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling. |
| % Held By Institutions | 12.60% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 15.30% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -482.66% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | N/A | -08.79% | Unknown. |
| Return on Assets % | -154.63% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $82,105.26 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | N/A | 5.52 | Unknown. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|